Search Results for "Top 100 Pharma Companies"
Original Source: The Top 100 Pharmaceutical Companies
The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and 2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ~ 57,747 Sanofi ~ 46,454 Novartis&n...
Matching Channels
After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...
Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...
The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...
The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...
Boehringer Ingelheim is a global pharmaceutical company with annual sales of over $16 billion, making it the 10th largest pharmaceutical company in the world based on sales. With bases in 47 c...
Matching News
Pharma 3.0 Pulls Companies into the Digital Future
Social media and mobile marketing have kick-started the pharma industry into a phase dubbed Pharma 3.0. Gone are the days of Pharma 1.0 in which companies could rely on a handful of blockbuster drug...
R&D pharma companies - comment from the Economist Intelligence Unit
Few people disagree that small drug discovery companies are vital to the health of the UK's pharma industry, and central to the government's aim of innovation-led growth. But private backers...
Who is determining the reputation of Pharma?
As corporate bodies, the reputation of pharma companies was typically of concern to shareholders, but generally determined by the industry or experts. Although a report just published, The Corporate...
Drugmakers offer to cap Greece's medicines bill - comment from the Economist Intelligence Unit
Pharmaceutical companies have long struggled to secure payment from Greek hospitals, whose debt problems predate the euro crisis. According to the Hellenic Association of Pharmaceutical Companies, t...
Drug industry productivity set to improve
The improvement in drug launches - and the drop in Phase III terminations - suggests that pharma companies' efforts to focus research funding only on the most promising area are paying dividends...
Are DTC Ads Falling Out of Favor with Pharma Companies?
With the Super Bowl only days away, all the chatter has turned to the most interesting aspect of this beloved American tradition — the TV ads. What products will we see? Whose commercial will be...
China Pharma Companies Look To Go Global With Affordable ARVs
The UN plans to increase access to antiretroviral therapy in low- and middle-income countries, providing Chinese pharma companies with a potential opportunity to manufacture generics for the global ma...
Chinese drug approval powers - comments from Economist Intelligence Unit
As China selects its new leaders and tries to shore up economic growth, it continues to push ahead with decentralisation of business investment decisions. Though this is widely seen as the best way...
Matching PubMed Articles
StatBite Top 10 Pharmaceutical Companies.
Companies hope for kinase inhibitor JAKpot.
Of Ephs and Ephrins: Companies Target Guidance Molecules in Cancer.
Structures containing the (R)-3-amino-3-methyl piperidine unit as a new pharmacophore moiety have been shown to possess moderate inhibitory activity for DPP-4 with good pharmacokinetics profile. One o...
